STOCK TITAN
  1. Home
  2. Sec-filings
  3. GDTC
  4. [6-K] – CytoMed Therapeutics Ltd (GDTC) (CIK 0001873093)

[6-K] – CytoMed Therapeutics Ltd (GDTC) (CIK 0001873093)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock GDTC logo
CytoMed Therapeutics Ltd

NASDAQ:GDTC

GDTC Rankings

#5843 Ranked by Market Cap
N/A Ranked by Dividends

GDTC Latest News

Oct 14, 2025
CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets
Oct 2, 2025
CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia 
Aug 28, 2025
Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition
Aug 18, 2025
CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program
Jul 21, 2025
Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies

GDTC Latest SEC Filings

Oct 2, 2025
[6-K] CytoMed Therapeutics Ltd Current Report (Foreign Issuer)
Sep 30, 2025
[6-K] CytoMed Therapeutics Ltd Current Report (Foreign Issuer)
Sep 22, 2025
[144] CytoMed Therapeutics Ltd SEC Filing
Sep 22, 2025
[144] CytoMed Therapeutics Ltd SEC Filing
Aug 28, 2025
[6-K] CytoMed Therapeutics Limited Current Report (Foreign Issuer)

GDTC Stock Data

22.65M
3.59M
68.86%
0.43%
0.29%
Biotechnology
Healthcare
Link
Singapore
Singapore